$GNPX News Article - Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA in Combination with Tagrisso in Advanced Non-Small Cell Lung Cancer
https://marketwirenews.com/news-releases/genp...21194.html